Biora Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
BIOR on Nasdaq
Industry
Pharmaceutical Preparations
Location
4330 La Jolla Village Drive, Suite 200, San Diego, CA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Biora Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Athyrium Opportunities Fund (A) LP 10%+ Owner $114M Jun 14, 2021
Athyrium Capital Management, LP 10%+ Owner $114M Jun 14, 2021
Harry Stylli Chairman & CEO, Director, 10%+ Owner $46.5M Aug 15, 2021
Athyrium Opportunities III Co-Invest 1 LP Director, 10%+ Owner $34.3M Aug 12, 2024
Aditya P. Mohanty Chief Executive Officer, Director $984K Aug 15, 2024
Damon Silvestry President and General Manager, Avero $915K Nov 15, 2021
Matthew T. Cooper General Manager, Diagnostics $421K Nov 15, 2021
Sami Shihabi Chief Commercial Officer $396K May 15, 2021
Eric dEsparbes Chief Financial Officer $386K Aug 15, 2024
Clarke Neumann Officer $312K Aug 15, 2024
Troy Seelye Chief Information Officer $188K Aug 6, 2021
Samuel R. Nussbaum Director $149K Jun 14, 2021
John T. Bigalke Director $149K Jun 14, 2021
Hutan Hashemi Chief Compliance Officer $89.5K Feb 15, 2022
Jill A. Howe Director $61K Jun 5, 2024
Jeffrey D. Alter Director $59.8K Jun 5, 2024
Lynne Powell Director $57.3K Jun 5, 2024
Brian L. Kotzin Director $57.3K Jun 5, 2024
Surbhi Sarna Director Jan 3, 2023

Recent Insider Transactions by Companies or Individuals for Biora Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.